MSB 2.17% $1.13 mesoblast limited

Cell Therapy News/Articles, page-17826

  1. 15,487 Posts.
    lightbulb Created with Sketch. 5576
    The word is getting out there .... slowly .... now let me see a CHF partnership deal before we even get a response from the FDA - we don't have the funds to wait for a Jan 2025 FDA decision; run the CLBP trial on our own and cover ongoing costs no matter what the company or people on here claim about the 'cash runway' ... simples !


    @Mesoblast announced that the US @FDA has accepted its Biologics License Application resubmission for Ryoncil® in the treatment of children with steroid-refractory acute graft-versus-host disease.

    Learn more in the press release: https://bit.ly/4feJSWh


    https://x.com/MesenchymalCell/status/1816231658107842789
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.13
Change
-0.025(2.17%)
Mkt cap ! $1.284B
Open High Low Value Volume
$1.15 $1.16 $1.11 $7.363M 6.488M

Buyers (Bids)

No. Vol. Price($)
5 94863 $1.13
 

Sellers (Offers)

Price($) Vol. No.
$1.13 5000 2
View Market Depth
Last trade - 16.10pm 26/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.